Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? [Yahoo! Finance]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Yahoo! Finance
10x Genomics to research transplant organ rejection and support clinical diagnostic development. The CEO's pre-planned sale of 19,480 shares under a Rule 10b5-1 program contrasts with operational momentum, highlighting how insider activity can appear out of sync with underlying business progress. Next, we'll examine how CareDx's revenue growth and collaboration with 10x Genomics may shape its investment narrative for transplant-focused diagnostics. Uncover the next big thing with financially sound penny stocks that balance risk and reward To own CareDx, you need to believe in its ability to turn a focused transplant-testing niche into a durable, profitable diagnostics franchise, supported by clinically relevant data and deeper integration into transplant workflows. The latest quarter's 25% revenue growth and the 10x Genomics collaboration reinforce that story, but they do not fundamentally change the near term catalysts, which still hinge on sustained test volume growth, evide
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings [Yahoo! Finance]Yahoo! Finance
- CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem MeetingsBusiness Wire
- CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 [Yahoo! Finance]Yahoo! Finance
- CareDx President and CEO Sells 19,000 Shares for $412,000 [Yahoo! Finance]Yahoo! Finance
- CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference [Yahoo! Finance]Yahoo! Finance
CDNA
Earnings
- 11/4/25 - Beat
CDNA
Sec Filings
- 2/4/26 - Form 4
- 2/4/26 - Form 4
- 2/4/26 - Form 4
- CDNA's page on the SEC website